ストックスクリーナーアプリを入手
1.09
2.83%
0.03
前日終値:
$1.06
開ける：
$1.07
24時間の取引高:
47,047
Relative Volume:
0.04
時価総額：
$137.35M
収益：
$4.75M
当期純損益:
$-7.83M
株価収益率:
5.0069
EPS:
0.2177
ネットキャッシュフロー:
$-7.24M
1週間 パフォーマンス:
+6.86%
1か月 パフォーマンス:
-0.91%
6か月 パフォーマンス:
+82.58%
1年 パフォーマンス:
+91.26%
1日の値動き範囲:
$1.01
$1.09
1週間の範囲:
$1.00
$1.11
52週間の値動き範囲:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
名前
Novabay Pharmaceuticals Inc
セクター
電話
510-899-8800
住所
2000 Powell Street, Suite 1150, Emeryville, CA
NBY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.09 | 133.57M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-09-18 | 開始されました | Ladenburg Thalmann | Buy |
| 2018-07-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-11-15 | 繰り返されました | Laidlaw | Buy |
| 2017-06-05 | 開始されました | ROTH Capital | Buy |
| 2017-03-27 | 開始されました | Laidlaw | Buy |
| 2017-02-06 | 開始されました | Rodman & Renshaw | Buy |
| 2016-03-07 | ダウングレード | Maxim Group | Buy → Hold |
| 2015-12-14 | 繰り返されました | Maxim Group | Buy |
| 2015-04-30 | 再開されました | Maxim Group | Buy |
| 2013-03-06 | 開始されました | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 開始されました | Dawson James | Speculative Buy |
すべてを表示
Novabay Pharmaceuticals Inc (NBY) 最新ニュース
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionInsider Selling & Weekly Top Gainers Trade List - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat growth indexesQuarterly Market Review & Real-Time Stock Price Movement Reports - Newser
Why Did KALA BIO Shares Jump Over 22% After Hours? - Benzinga
Is NovaBay Pharmaceuticals Inc. stock dividend yield sustainableJuly 2025 Closing Moves & Proven Capital Preservation Tips - Newser
Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosFed Meeting & Fast Gain Stock Trading Tips - Newser
Will NovaBay Pharmaceuticals Inc. stock recover faster than industryPortfolio Gains Summary & Safe Entry Momentum Stock Tips - Newser
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock split2025 Dividend Review & Safe Capital Investment Plans - Newser
Can NovaBay Pharmaceuticals Inc. stock double in coming years2025 Price Momentum & Growth Oriented Trade Recommendations - Newser
How NovaBay Pharmaceuticals Inc. stock benefits from strong dollar - BỘ NỘI VỤ
Will NovaBay Pharmaceuticals Inc. stock outperform tech sector in 2025Quarterly Growth Report & Breakout Confirmation Alerts - BỘ NỘI VỤ
[S-8] NovaBay Pharmaceuticals, Inc. Employee Benefit Plan Registration | NBY SEC FilingForm S-8 - Stock Titan
What Sparked KALA BIO's Nearly 38% Surge Overnight? - Benzinga
[S-3/A] NovaBay Pharmaceuticals, Inc. Amended Shelf Registration Statement | NBY SEC FilingForm S-3/A - Stock Titan
NovaBay Pharmaceuticals Inc. (NBY) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
How NovaBay Pharmaceuticals Inc. stock trades under stagflationJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock beat revenue estimatesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Will NovaBay Pharmaceuticals Inc. stock deliver compounding returns2025 Stock Rankings & Weekly Setup with ROI Potential - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock rise with strong economyWeekly Trade Summary & Safe Entry Momentum Tips - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock performs during market turbulence - newser.com
Can NovaBay Pharmaceuticals Inc. stock deliver sustainable ROEMarket Growth Report & High Conviction Investment Ideas - newser.com
Is NovaBay Pharmaceuticals Inc. stock a momentum leaderTrade Volume Report & Daily Oversold Stock Bounce Ideas - newser.com
Is NovaBay Pharmaceuticals Inc. stock suitable for passive index fundsBull Run & Verified Stock Trade Ideas - newser.com
How NovaBay Pharmaceuticals Inc. (B9P0) stock correlates with oil marketsNew Guidance & Verified Momentum Stock Watchlist - newser.com
Is NovaBay Pharmaceuticals Inc. stock at risk of policy regulationWeekly Trade Recap & Intraday High Probability Alerts - newser.com
How NovaBay Pharmaceuticals Inc. stock reacts to stronger dollar - newser.com
Why millennials buy NovaBay Pharmaceuticals Inc. stockMarket Weekly Review & Verified Swing Trading Watchlist - newser.com
Can NovaBay Pharmaceuticals Inc. stock beat analyst consensusEarnings Risk Summary & Real-Time Volume Analysis Alerts - newser.com
Novabay Pharmaceuticals Inc (NBY) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):